secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001654954-23-003859
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenax Therapeutics receives Nasdaq bid price deficiency notice; 180 days to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified Tenax on March 29, 2023 that bid price closed below $1.00 for 30 consecutive business days.
- Company has until September 25, 2023 to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, Company may be eligible for additional 180-day period if it meets other listing standards.
- No immediate effect on listing; stock continues trading under TENX on Nasdaq Capital Market.
- Company evaluating options including potential reverse stock split to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495423003859/0001654954-23-003859-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495423003859/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-003859

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer